Home About us Contact | |||
Lead Perforation (lead + perforation)
Selected AbstractsOld is Gold: Tip Electrograms to Diagnose Pacemaker Lead PerforationJOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, Issue 10 2002KIRAN CHANDAN M.D. [source] Inadequate ICD Discharges Due to Diaphragmatic Electromyopotential Oversensing as the First Sign of Right Ventricular Lead PerforationPACING AND CLINICAL ELECTROPHYSIOLOGY, Issue 10 2006UWE K. H. WIEGAND M.D. Right ventricular lead perforation, when acute, is a rare but potentially life-threatening complication of implantable cardioverter defibrillator (ICD) therapy. We report about a patient with early lead perforation presenting with repetitive ICD discharges due to oversensing of diaphragmatic electromyopotentials and describe the management of this complication. [source] Does Size Really Matter?PACING AND CLINICAL ELECTROPHYSIOLOGY, Issue 6 2008A Comparison of the Riata Lead Family Based on Size, Its Relation to Performance Background: Recently, the performance and safety of smaller diameter implantable cardioverter defibrillator (ICD) leads has been questioned. The purpose of this analysis was to determine the impact of size on lead performance and perforation rates by comparing the performance of 7 French (7F) and 8 French (8F) leads with similar design characteristics implanted by a single operator. Methods: Patients implanted with a Riata 1580 (8F) or 7000 (7F) series leads (St. Jude Medical, Sylmar, CA, USA) over a 2-year period were evaluated to compare performance and perforation rates. Results: There were 357 Riata 8F leads and 357 Riata 7F leads implanted in 714 patients. Follow-up ranged from 1 to 24 months. The 8F leads were implanted in the right ventricular apex more often than were 7F leads (129 or 37% vs 72 or 20%, P < 0.0001). Oversensing that did not result in therapy occurred in 2 pts (0.56%) with 8F leads and 1 pt. (0.28%) with a 7F lead (P = 0.56). Oversensing with therapy occurred once in both groups (0.28%, P = NS). One perforation occurred in each group (0.28%, P = NS). Both occurred in leads that were implanted in the right ventricular apex (P = 0.02). Conclusions: The performance of St. Jude Medical 7F and 8F Riata leads was similar. The incidence of lead-related adverse events was within or below the low end of published acceptable ranges for ICD lead perforation and sensing anomalies. Perforations were less likely to occur in leads that were implanted in nonapical positions. [source] Inadequate ICD Discharges Due to Diaphragmatic Electromyopotential Oversensing as the First Sign of Right Ventricular Lead PerforationPACING AND CLINICAL ELECTROPHYSIOLOGY, Issue 10 2006UWE K. H. WIEGAND M.D. Right ventricular lead perforation, when acute, is a rare but potentially life-threatening complication of implantable cardioverter defibrillator (ICD) therapy. We report about a patient with early lead perforation presenting with repetitive ICD discharges due to oversensing of diaphragmatic electromyopotentials and describe the management of this complication. [source] Postpacemaker Implant Pericarditis: Incidence and Outcomes with Active-Fixation LeadsPACING AND CLINICAL ELECTROPHYSIOLOGY, Issue 5 2002SOORI SIVAKUMARAN SIVAKUMARAN, S., et al.: Postpacemaker Implant Pericarditis: Incidence and Outcomes with Active Fixation Leads. Pericarditis has been noted as a potential complication of pacemaker implantation. This study evaluated the risk of developing pericarditis following pacemaker implantation with active-fixation atrial leads. Included were 1,021 consecutive patients (mean age 73.4 ± 0.4 years, range 16,101 years; 45.2% women) undergoing new pacemaker system implantation between 1991 and 1999 who were reviewed for the complication of pericarditis. The incidence and outcomes of postimplantation pericarditis in patients receiving active-fixation atrial leads were compared to those not receiving these leads. Of 79 patients who received active-fixation atrial leads, 4 (5%) developed pericarditis postpacemaker implantation. Of 942 patients with passive-fixation atrial leads or no atrial lead (i.e., a ventricular lead only), none developed pericarditis postoperatively (P < 0.001). Of patients receiving active-fixation ventricular leads only (n = 97), none developed pericarditis. No complications were apparent at the time of implantation in patients who developed pericarditis. Pleuritic chest pain developed between 1 and 28 hours postoperatively. Three patients had pericardial rubs without clinical or echocardiographic evidence of tamponade. They were treated conservatively with acetylsalicylic acid or ibuprofen and their symptoms resolved without sequelae in 1,8 days. One patient (without pericardial rub) died due to cardiac tamponade on postoperative day 6. Postmortem examination revealed hemorrhagic pericarditis with no gross evidence of lead perforation. Pericarditis complicates pacemaker implantation in significantly more patients who receive active-fixation atrial leads. It may be precipitated by perforation of the atrial lead screw through the thin atrial wall. Patients developing postoperative pericarditis should be followed closely due to the risk of cardiac tamponade. [source] Late Perforation by Cardiac Implantable Electronic Device Leads: Clinical Presentation, Diagnostic Clues, and ManagementCLINICAL CARDIOLOGY, Issue 8 2010Marwan M. Refaat MD Late intracardiac lead perforation is defined as migration and perforation of an implanted lead after 1 month of cardiac electronic device implantation. It is an under-recognized complication with significant morbidity and mortality, particularly if not recognized early. Two patients with late perforation caused by passive-fixation leads are reported and the clinical features of their presentation and management are reviewed. We conducted a thorough review of the available English language literature pertaining to this complication to draw relevant conclusions regarding presentation, diagnosis, and management. Early recognition of this complication is important as the indications for and numbers of patients who receive cardiac implantable electronic devices continue to expand. Copyright © 2010 Wiley Periodicals, Inc. The authors have no funding, financial relationships, or conflicts of interest to disclose. [source] "Sensing alternans" in a patient with a newly implanted pacemakerCLINICAL CARDIOLOGY, Issue 3 2006Amgad N. Makaryus M.D. Abstract This report describes the case of an 80-year-old man with a history of coronary artery disease who presented with acute pericarditis secondary to pacemaker lead perforation of the ventricular wall 2 days after undergoing dual lead pacemaker implantation. The electrocardiogram revealed sinus rhythm with an intra-atrial conduction delay and intermittent failure of atrial sensing as evidenced by alternating atrial spikes in every other P wave. The noted pericardial effusion and the likely shifting of the atrial lead with each alternate beat caused the "sensing alternans" that was seen on the admission electrocardiogram. [source] |